News and Stories

Type 1 diabetes (T1D) is an autoimmune disease in which the body’s immune system destroys the cells in the pancreas that produce insulin. The disease most commonly starts in childhood but can develop in adults as well. As a result of damage to the pancreas, high blood sugars (hyperglycemia) occur and daily insulin treatment is needed.

Guest Contributor | February 27, 2023

Ramona Koren remembers “falling apart” when she was diagnosed with type 2 diabetes a decade ago. Her life turned upside down, and she had “no clue” what to do next.

Chris Casey | February 15, 2023

An ancient human foraging instinct, fueled by fructose production in the brain, may hold clues to the development and possible treatment of Alzheimer’s disease (AD), according to researchers at the University of Colorado Anschutz Medical Campus.

David Kelly | February 13, 2023

When a Twitter follower praised Elon Musk’s new “awesome, fit, ripped and healthy” look, the billionaire entrepreneur replied that his secret was “fasting” and “Wegovy.” Given society’s obsession with celebrities and weight loss and Musk’s massive following on Twitter, a viral tweet was born.

Chris Casey | October 19, 2022

After overcoming the challenges of setting up a program as the pandemic descended on Colorado, the University of Colorado Diabetes Research Center (DRC) seems to be hitting its stride.

Guest Contributor | May 09, 2022

Acute amounts of lactate like those generated during exercise are probably required for healthy cells, but chronic exposure causes cellular disruption which can lead to cancer, heart failure and type 2 diabetes, according to a new study by scientists at the University of Colorado Anschutz Medical Campus.

David Kelly | March 10, 2022

After hearing the phrase “dead in bed,” restful nights for Marc Bullion and his wife, Becki, disappeared. Their daughter, Lelia, was diagnosed with type 1 diabetes (T1D) at age 8, and her low-blood sugar episodes were unusually frequent.

Debra Melani | January 31, 2022

Racing through the Pyrenees near the end of the three-week battle of attrition that is the Tour de France, Tadej Pogačar accelerated up a 14% grade and dropped his nearest competitors as if they were slogging through a bog. Pogačar, 22, was on his way to his second Le Tour championship in a row, finishing 5 minutes, 20 seconds ahead of his nearest rival.

Chris Casey | July 26, 2021

Taking a first look at COVID-19’s effects on children and adolescents with Type 1 diabetes (T1D), researchers have linked ethnic minority status, poor blood-sugar control and diabetic ketoacidosis (DKA) with increased hospitalization.

Debra Melani | April 28, 2021

Researchers from the Barbara Davis Center for Diabetes at the University of Colorado Anschutz Medical Campus have found that immune responses to insulin could help identify individuals most at risk for developing Type 1 diabetes. 

Kelsea Pieters | February 08, 2021

Researchers at the University of Colorado Anschutz Medical Campus have discovered a direct association between placental function in pregnant women and future metabolic disorders in children and adults, a finding that could lead to earlier intervention and diagnosis of disease. 

David Kelly | January 21, 2021

Researchers at the University of Colorado Anschutz Medical Campus have discovered that fructose stimulates the release of vasopressin, a hormone linked to obesity and diabetes. They also found that water can suppress the hormone and alleviate these conditions in mice. 

David Kelly | December 15, 2020

To say cycling enthusiasts were stunned by the Tour de France performance of rookie rider Tadej Pogačar might be an understatement. Jaws dropped as the 21-year-old Slovenian, the second-youngest rider to ever win the Tour, ascended the final 5.9-kilometer final climb of the time trial and secured the yellow jersey.

Chris Casey | October 21, 2020